Hyperoside Suppresses Renal Inflammation by Regulating Macrophage Polarization in Mice With Type 2 Diabetes Mellitus

Jialing Liu,Yanmei Zhang,Hongqin Sheng,Chunling Liang,Huazhen Liu,Jose Alberto Moran Guerrero,Zhaoyu Lu,Wei Mao,Zhenhua Dai,Xusheng Liu,Lei Zhang
DOI: https://doi.org/10.3389/fimmu.2021.733808
IF: 7.3
2021-12-03
Frontiers in Immunology
Abstract:Accumulating evidence reveals that both inflammation and lymphocyte dysfunction play a vital role in the development of diabetic nephropathy (DN). Hyperoside (HPS) or quercetin-3-O-galactoside is an active flavonoid glycoside mainly found in the Chinese herbal medicine Tu-Si-Zi. Although HPS has a variety of pharmacological effects, including anti-oxidative and anti-apoptotic activities as well as podocyte-protective effects, its underlying anti-inflammatory mechanisms remain unclear. Herein, we investigated the therapeutic effects of HPS on murine DN and the potential mechanisms responsible for its efficacy. We used C57BLKS/6J Lep db/db mice and a high glucose (HG)-induced bone marrow-derived macrophage (BMDM) polarization system to investigate the potentially protective effects of HPS on DN. Our results showed that HPS markedly reduced diabetes-induced albuminuria and glomerular mesangial matrix expansion, accompanied with a significant improvement of fasting blood glucose level, hyperlipidaemia and body weight. Mechanistically, pretreatment with HPS effectively regulated macrophage polarization by shifting proinflammatory M1 macrophages (F4/80 + CD11b + CD86 + ) to anti-inflammatory M2 ones (F4/80 + CD11b + CD206 + ) in vivo and in bone marrow-derived macrophages (BMDMs) in vitro , resulting in the inhibition of renal proinflammatory macrophage infiltration and the reduction in expression of monocyte chemoattractant protein-1 (MCP-1), tumor necrosis factor (TNF-α) and inducible nitric oxide synthase (iNOS) while increasing expression of anti-inflammatory cytokine Arg-1 and CD163/CD206 surface molecules. Unexpectedly, pretreatment with HPS suppressed CD4 + T cell proliferation in a coculture model of IL-4-induced M2 macrophages and splenic CD4 + T cells while promoting their differentiation into CD4 + IL-4 + Th2 and CD4 + Foxp3 + Treg cells. Taken together, we demonstrate that HPS ameliorates murine DN via promoting macrophage polarization from an M1 to M2 phenotype and CD4 + T cell differentiation into Th2 and Treg populations. Our findings may be implicated for the treatment of DN in clinic.
immunology
What problem does this paper attempt to address?